Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Stem Cell Research

Free Subscription Articles published in Oncogene Retrieve available abstracts of 40 articles: HTML format

Single Articles

March 2023
1. MA Y, Zhu Y, Shang L, Qiu Y, et al
   LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.
   Oncogene. 2023 Mar 15. doi: 10.1038/s41388-023-02652.
   PubMed     Abstract available
   
   
   
2. VORONTSOVA A, Cooper TJ, Haj-Shomaly J, Benguigui M, et al
   Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors.
   Oncogene. 2023;42:771-781.
   PubMed     Abstract available
   
   
   
3. AN N, Khan S, Imgruet MK, Jueng L, et al
   Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
   Oncogene. 2023;42:881-893.
   PubMed     Abstract available
   
   
   February 2023
4. KWON JW, Seok SH, Kim S, An HW, et al
   A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.
   Oncogene. 2023;42:501-515.
   PubMed     Abstract available
   
   
   January 2023
5. CHEN F, Gurler SB, Novo D, Selli C, et al
   RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
   Oncogene. 2023 Jan 5. doi: 10.1038/s41388-022-02574.
   PubMed     Abstract available
   
   
   December 2022
6. YU T, Zhou F, Tian W, Xu R, et al
   EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
   Oncogene. 2022 Dec 14. doi: 10.1038/s41388-022-02570.
   PubMed     Abstract available
   
   
   
7. LI F, Niu M, Qin K, Guo R, et al
   FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance.
   Oncogene. 2022 Dec 2. doi: 10.1038/s41388-022-02559.
   PubMed     Abstract available
   
   
   
8. SONG YL, Yang MH, Zhang S, Wang H, et al
   A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.
   Oncogene. 2022;41:5223-5237.
   PubMed     Abstract available
   
   
   November 2022
9. SPINA R, Mills I, Ahmad F, Chen C, et al
   DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts.
   Oncogene. 2022 Nov 7. pii: 10.1038/s41388-022-02517.
   PubMed     Abstract available
   
   
   July 2022
10. BALINTH S, Fisher ML, Hwangbo Y, Wu C, et al
    EZH2 regulates a SETDB1/DeltaNp63alpha axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.
    Oncogene. 2022 Jul 21. pii: 10.1038/s41388-022-02417.
    PubMed     Abstract available
    
    
    June 2022
11. BUSCHHAUS JM, Rajendran S, Humphries BA, Cutter AC, et al
    Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.
    Oncogene. 2022 Jun 22. pii: 10.1038/s41388-022-02385.
    PubMed     Abstract available
    
    
    May 2022
12. LORENZO-MARTIN LF, Menacho-Marquez M, Fernandez-Parejo N, Rodriguez-Fdez S, et al
    The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function.
    Oncogene. 2022 May 9. pii: 10.1038/s41388-022-02341.
    PubMed     Abstract available
    
    
    April 2022
13. KUDARAVALLI S, den Hollander P, Mani SA
    Role of p38 MAP kinase in cancer stem cells and metastasis.
    Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02329.
    PubMed     Abstract available
    
    
    
14. LANE R, Cilibrasi C, Chen J, Shah K, et al
    PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling.
    Oncogene. 2022 Apr 7. pii: 10.1038/s41388-022-02294.
    PubMed     Abstract available
    
    
    March 2022
15. YANG YS, Jia XZ, Lu QY, Cai SL, et al
    Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.
    Oncogene. 2022 Mar 29. pii: 10.1038/s41388-022-02278.
    PubMed     Abstract available
    
    
    
16. SONG H, Wang J, Wang X, Yuan B, et al
    HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
    Oncogene. 2022 Mar 22. pii: 10.1038/s41388-022-02271.
    PubMed     Abstract available
    
    
    
17. LEE WK, Zhu X, Park S, Zhu YJ, et al
    Regulation of cancer stem cell activity by thyroid hormone receptor beta.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02242.
    PubMed     Abstract available
    
    
    
18. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    PubMed     Abstract available
    
    
    
19. ZHANG T, Wang Y, Li Q, Lin L, et al
    Mesenchymal stromal cells equipped by IFNalpha empower T cells with potent anti-tumor immunity.
    Oncogene. 2022;41:1866-1881.
    PubMed     Abstract available
    
    
    February 2022
20. TURDO A, Gaggianesi M, Di Franco S, Veschi V, et al
    Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51.
    Oncogene. 2022 Feb 25. pii: 10.1038/s41388-022-02239.
    PubMed     Abstract available
    
    
    
21. YUAN S, Zhang P, Wen L, Jia S, et al
    Correction: miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma.
    Oncogene. 2022 Feb 4. pii: 10.1038/s41388-022-02188.
    PubMed    
    
    
    January 2022
22. ZOU H, Luo J, Guo Y, Liu Y, et al
    RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7.
    Oncogene. 2022 Jan 31. pii: 10.1038/s41388-022-02198.
    PubMed     Abstract available
    
    
    
23. FU L, Fan J, Maity S, McFadden G, et al
    PD-L1 interacts with Frizzled 6 to activate beta-catenin and form a positive feedback loop to promote cancer stem cell expansion.
    Oncogene. 2022 Jan 17. pii: 10.1038/s41388-021-02144.
    PubMed     Abstract available
    
    
    
24. CHEN J, Hou SF, Tang FJ, Liu DS, et al
    HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.
    Oncogene. 2022;41:99-111.
    PubMed     Abstract available
    
    
    
25. LEON F, Seshacharyulu P, Nimmakayala RK, Chugh S, et al
    Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer.
    Oncogene. 2022;41:57-71.
    PubMed     Abstract available
    
    
    November 2021
26. CHEN Y, Zhao H, Liang W, Jiang E, et al
    Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02115.
    PubMed     Abstract available
    
    
    October 2021
27. GAO S, Soares F, Wang S, Wong CC, et al
    CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
    Oncogene. 2021 Oct 7. pii: 10.1038/s41388-021-01882.
    PubMed     Abstract available
    
    
    August 2021
28. YAN Y, Narayan A, Cho S, Cheng Z, et al
    CRYbetaB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
    Oncogene. 2021 Aug 2. pii: 10.1038/s41388-021-01975.
    PubMed     Abstract available
    
    
    
29. PAL A, Barrett TF, Paolini R, Parikh A, et al
    Partial EMT in head and neck cancer biology: a spectrum instead of a switch.
    Oncogene. 2021;40:5049-5065.
    PubMed     Abstract available
    
    
    
30. MELOCCHI V, Dama E, Mazzarelli F, Cuttano R, et al
    Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Oncogene. 2021;40:4980-4991.
    PubMed     Abstract available
    
    
    
31. BAUER J, Cuvelier N, Ragab N, Simon-Keller K, et al
    Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
    Oncogene. 2021;40:4955-4966.
    PubMed     Abstract available
    
    
    July 2021
32. LI Y, Fei H, Lin Q, Liang F, et al
    ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Oncogene. 2021 Jul 1. pii: 10.1038/s41388-021-01913.
    PubMed     Abstract available
    
    
    June 2021
33. ZHANG J, Guan W, Xu X, Wang F, et al
    A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01891.
    PubMed     Abstract available
    
    
    
34. TRUONG TH, Benner EA, Hagen KM, Temiz NA, et al
    PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01871.
    PubMed     Abstract available
    
    
    
35. NATHANSEN J, Lukiyanchuk V, Hein L, Stolte MI, et al
    Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Oncogene. 2021;40:4214-4228.
    PubMed     Abstract available
    
    
    May 2021
36. LAGER TW, Conner C, Keating CR, Warshaw JN, et al
    Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01821.
    PubMed     Abstract available
    
    
    April 2021
37. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available
    
    
    
38. BLOKZIJL-FRANKE S, Ponsioen B, Schulte-Merker S, Herbomel P, et al
    Phosphatidylinositol-3 kinase signaling controls survival and stemness of hematopoietic stem and progenitor cells.
    Oncogene. 2021;40:2741-2755.
    PubMed     Abstract available
    
    
    March 2021
39. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
    CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
    PubMed     Abstract available
    
    
    
40. LEE HC, Ou CH, Huang YC, Hou PC, et al
    YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer.
    Oncogene. 2021 Mar 4. pii: 10.1038/s41388-021-01718.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: